Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05183984
Title Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer (NIRVANA-1)
Acronym NIRVANA-1
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors ARCAGY/ GINECO GROUP
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.